Drug release á724ñ
Medium:
water;900mL,1800mLfor 400-mg Tablets.
Apparatus 1:
100rpm.
Times:
3,6,12,and 24hours.
Procedure
Determine the amount of C
15H
12N
2Odissolved by employing UVabsorption at the wavelength of maximum absorbance at about 284nm on filtered portions of the solution under test,suitably diluted with
Dissolution Medium,if necessary,in comparison with a Standard solution having a known concentration of
USP Carbamazepine RSin the same
Medium.
Tolerances
The percentages
(Q)of the labeled amount of C
15H
12N
2Odissolved at the times specified conform to
Acceptance Table 1.
| Time (hours) |
Amount dissolved |
| 3 |
between 10%and 35% |
| 6 |
between 35%and 65% |
| 12 |
between 65%and 90% |
| 24 |
not less than 75% |
Uniformity of dosage units á905ñ:
meet the requirements.
PROCEDUREFOR CONTENT UNIFORMITY
Standard stock solution
Dissolve an accurately weighed quantity of USP Carbamazepine RSin methanol to obtain a solution containing 2mg per mL.
Standard solution
Quantitatively dilute an accurately measured volume of Standard stock solutionwith methanol to obtain a solution having a known concentration of 10µg per mL.
Test solution
Finely powder 1Tablet,and quantitatively transfer the powder,with the aid of methanol,to a 100-mLvolumetric flask.Add about 70mLof methanol,and shake by mechanical means for 60minutes.Sonicate for 15minutes,and dilute with methanol to volume.Allow to stand for 10to 15minutes.Dilute a portion of the clear solution quantitatively,and stepwise if necessary,with methanol to obtain a solution containing about 10µg of carbamazepine per mL.
Procedure
Concomitantly determine the absorbances of the
Test solutionand the
Standard solutionby employing UVabsorption at the wavelength of maximum absorbance at about 284nm,using methanol as a blank.Calculate the quantity,in mg,of carbamazepine (C
15H
12N
2O)in the Tablet taken by the formula:
(LC/D)(AU/AS),
in which
Lis the labeled quantity,in mg,of carbamazepine in the Tablet;
Cis the concentration,in µg per mL,of
USP Carbamazepine RSin the
Standard solution;Dis the concentration,in µg per mL,of the
Test solution,based on the labeled quantity per Tablet and the extent of dilution;and
AUand
ASare the absorbances obtained from the
Test solutionand the
Standard solution,respectively.
Limit of residual solvents
Standard solution
Dissolve accurately measured quantities of methanol and methylene chloride in dimethylformamide to obtain a solution having known concentrations of about 5µg of each per mL.
Test solution
Finely powder 10Tablets,and quantitatively transfer the powder to a 50-mLvolumetric flask.Add about 30mLof dimethylformamide,shake by mechanical means for 60minutes,and sonicate for 2minutes.Dilute with dimethylformamide to volume,and mix.Centrifuge a portion of the solution at about 2500rpm for 20minutes,and use the clear supernatant.
Chromatographic system(seeChromatography á621ñ)
The gas chromatograph is equipped with a flame-ionization detector and a 2-mm ×3-m glass column containing 0.2%phase G39on support S7.The injection port and detector temperatures are maintained at about 170

and 300

,respectively.The column temperature is programmed as follows.Initially it is maintained at 75

for 10minutes,then increased at a rate of 20

per minute to 155

,and maintained at 155

for 30minutes.The carrier gas is helium,flowing at a rate of about 10mLper minute.
Procedure
Separately inject equal volumes (about 2µL)of the
Test solutionand the
Standard solutioninto the chromatograph,record the chromatograms,and measure the peak responses.Calculate the amount,in µg,of methylene chloride and methanol in each Tablet taken by the formula:
5C(rU/rS),
in which
Cis the concentration,in µg per mL,of methylene chloride or methanol in the
Standard solution;and
rUand
rSare the responses of the corresponding analyte obtained from the
Test solutionand the
Standard solution,respectively:not more than 23µg of methylene chloride per Tablet is found;and not more than 100µg of methanol per Tablet is found.
Chromatographic purity
Not more than 0.2%of any individual impurity is found;and not more than 0.5%of total impurities is found,the results from both
Test 1and
Test 2being used.
TEST1
Mobile phaseand Chromatographic system
Prepare as directed in the Assay.
System suitability solution
Dissolve suitable quantities of phenytoin and
USP Carbamazepine RSin methanol to obtain a solution containing about 0.6and 0.2mg per mL,respectively.Dilute this solution quantitatively,and stepwise if necessary,with methanol to obtain a solution containing about 60µg of phenytoin and 20µg of
USP Carbamazepine RSper mL.
Standard solution
Dissolve an accurately weighed quantity of
USP Carbamazepine RSin methanol,and dilute quantitatively,and stepwise if necessary,with methanol to obtain a solution having a known concentration of about 4µg per mL.
Test solution
Use the Assay stock preparation.
Procedure
Separately inject equal volumes (about 10µL)of the
Test solutionand the
Standard solutioninto the chromatograph,record the chromatograms,and measure the peak responses.Calculate the percentage of each impurity in the portion of Tablets taken by the formula:
100(CS/CT)(ri/rS),
in which
CSis the concentration,in mg per mL,of
USP Carbamazepine RSin the
Standard solution;CTis the concentration,in mg per mL,of carbamazepine in the
Test solution;riis the peak response of each impurity obtained from the
Test solution;and
rSis the peak response for carbamazepine obtained from the
Standard solution.
TEST2
Mobile phase
Prepare a filtered and degassed mixture of water,methanol,and acetonitrile (10:7:3).Make adjustments if necessary (see
System Suitabilityunder
Chromatography á621ñ).
System suitability solution
Dissolve suitable quantities of iminostilbene and
USP Carbamazepine RSin methanol to obtain a solution containing about 12.5and 5.0µg per mL,respectively.
Standard solution
Use the Standard solution,prepared as directed for Test 1.
Test solution
Use the Assay stock preparation.
Chromatographic system(see Chromatography á621ñ)
Prepare as directed in the
Assay.Chromatograph the
System suitability solution,and record the peak responses as directed for
Procedure:the relative retention times are about 0.3for carbamazepine and 1.0for iminostilbene;the resolution,
R,between carbamazepine and iminostilbene is not less than 10.0;and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Proceed as directed for Test 1.
Assay
Mobile phase
Prepare a filtered and degassed mixture of water,methanol,and methylene chloride (600:450:45).Make adjustments if necessary (see
System Suitabilityunder
Chromatography á621ñ).
Internal standard solution
Prepare a solution of phenytoin in methanol containing about 600µg per mL.
Standard preparation
Dissolve an accurately weighed quantity of
USP Carbamazepine RSin methanol,and dilute quantitatively,and stepwise if necessary,with methanol to obtain a solution having a known concentration of about 200µg per mL.Pipet 10.0mLof this solution into a conical flask,add 10.0mLof
Internal standard solution,mix,and filter.This solution contains about 100µg of
USP Carbamazepine RSper mL.
System suitability solution
Pipet equal volumes of Internal standard solutionand Standard preparationinto a suitable flask,and mix.
Assay stock preparation
Finely powder 10Tablets,and quantitatively transfer the powder,with the aid of alcohol,to a volumetric flask of such volume that when the solution is diluted to volume a final concentration estimated to be about 4mg of carbamazepine per mLis obtained.Shake by mechanical means for 60minutes.Sonicate for 15minutes,and dilute with methanol to volume.Allow to stand for 10to 15minutes,then filter a portion of the supernatant,and use the clear filtrate.
Assay preparation
Transfer 5.0mLof the Assay stock preparationto a 100-mLvolumetric flask,dilute with methanol to volume,and mix.Pipet 10.0mLof this solution into a conical flask,add 10.0mLof Internal standard solution,mix,and filter.
Chromatographic system(see Chromatography á621ñ)
The liquid chromatograph is equipped with a 230-nm detector,a 4.6-mm ×30-mm guard column that contains 7-µm packing L7,and a 3.9-mm ×30-cm column that contains packing L1.
[NOTEWash the column with 50to 100mLof methanol before and after use.
]The flow rate is about 2mLper minute.Chromatograph the
System suitability solution,and record the peak responses as directed for
Procedure:the relative retention times are about 0.8for phenytoin,and 1.0for carbamazepine;the resolution,
R,between phenytoin and carbamazepine is not less than 2.8;and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 10µL)of the
Standard preparationand the
Assay preparationinto the chromatograph,record the chromatograms,and measure the peak responses.Calculate the quantity,in mg,of carbamazepine (C
15H
12N
2O)in each Tablet taken by the formula:
0.004(CV)(RU/RS),
in which
Cis the concentration,in µg per mL,of
USP Carbamazepine RSin the
Standard preparation;Vis the volume,in mL,of the volumetric flask used to prepare the
Assay stock preparation;and
RUand
RSare the peak response ratios of carbamazepine to the internal standard obtained from the
Assay preparationand the
Standard preparation,respectively.